top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
UNC242
Multi-normal/disease tissues from 12 anatomic sites, serving as controls for >90% of the IHC markers currently used in pathology diagnostics, and for general antibody/probe screening and optimization.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$54
1 slide
In-Stock

Human
12
24
1.5mm
4um
4
6
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For Research use only. Designed for universal IHC/ISH control & antibody screening.

ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 5 | Tonsil | Tonsillitis | |||
A02 | M | 47 | Intestine, colon | Normal | |||
A03 | F | 53 | Thyroid | Normal | |||
A04 | M | 82 | Prostate | Normal, hyperplasia | |||
A05 | F | 49 | Breast | Invasive ductal carcinoma | II | T3N1M0 | |
A06 | M | 24 | Thymus | Thymoma | |||
B01 | M | 5 | Tonsil | Tonsillitis | |||
B02 | M | 47 | Intestine, colon | Normal | |||
B03 | F | 53 | Thyroid | Normal | |||
B04 | M | 82 | Prostate | Normal, hyperplasia | |||
B05 | F | 49 | Breast | Invasive ductal carcinoma | II | T3N1M0 | |
B06 | M | 24 | Thymus | Thymoma | |||
C01 | F | 16 | Brain, cerebral cortex | Normal* | |||
C02 | F | 53 | Lung | Normal | |||
C03 | M | 52 | Liver | Viral hepatitis related cirrhosis | |||
C04 | F | 48 | Uterus, myometrium | Normal | |||
C05 | F | 28 | Placenta | Normal | |||
C06 | M | 65 | Skin, foot | Melanoma | |||
D01 | F | 16 | Brain, cerebral cortex | Normal* | |||
D02 | F | 53 | Lung | Normal | |||
D03 | M | 52 | Liver | Viral hepatitis related cirrhosis | |||
D04 | F | 48 | Uterus, myometrium | Normal | |||
D05 | F | 28 | Placenta | Normal | |||
D06 | M | 65 | Skin, foot | Melanoma | |||
null |
bottom of page